Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial

California-based biotech company Gilead Sciences and the US government reported that in a major study, remdesivir shortened the time it takes for COVID-19 patients to recover by four days on average

The post Phase 3 results on Gilead coronavirus drug encouraging; a look at other potential COVID-19 treatments under trial appeared first on Firstpost.

from Firstpost